| Name | evobrutinib |
|---|---|
| Synonyms |
UNII:ZA45457L1K
1-[4-({[6-Amino-5-(4-phenoxyphenyl)-4-pyrimidinyl]amino}methyl)-1-piperidinyl]-2-propen-1-one 2-Propen-1-one, 1-[4-[[[6-amino-5-(4-phenoxyphenyl)-4-pyrimidinyl]amino]methyl]-1-piperidinyl]- evobrutinib |
| Description | Evobrutinib is an inhibitor of Bruton's tyrosin kinase (Btk) inhibitor extracted from patent US20140162983 example 0174. |
|---|---|
| Related Catalog |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 683.4±55.0 °C at 760 mmHg |
| Molecular Formula | C25H27N5O2 |
| Molecular Weight | 429.514 |
| Flash Point | 367.1±31.5 °C |
| Exact Mass | 429.216461 |
| LogP | 3.19 |
| Vapour Pressure | 0.0±2.1 mmHg at 25°C |
| Index of Refraction | 1.637 |